IP Library Granted Patent US 9,808,310
Granted Patent B2
US 9,808,310 · App. 12/973,642 · Granted Nov 7, 2017

Method and device for uterine fibroid treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,808,310
App. No.
12/973,642
Granted
Nov 7, 2017
Kind
B2
Abstract

Methods and devices for both imaging and treating uterine fibroid tumors in one real-time system are provided. One minimally invasive method comprises introducing a sheath into a uterus and determining a location of a fibroid using a visualization element within or on the sheath. Upon identification, a portion of the sheath is steered to position at least one treatment needle at the determined location. The needle is then anchored in uterine tissue and the fibroid treated with the needle.

Claims (17)

1. A method for minimally invasive treatment of uterine fibroids, said method comprising:

introducing a sheath into a uterus, said sheath having a longitudinal axis;

determining a location of a fibroid using a visualization element within or on the sheath, wherein the visualization element produces an imaging field transverse to the longitudinal axis of the sheath and wherein both the visualization element and the imaging field are deflectable with respect to the longitudinal axis of the sheath;

advancing a hollow needle from the sheath through a wall of the uterus and across the imaging field;

advancing a plurality of diverging needles from the hollow needle into the fibroid; and

treating the fibroid with the diverging needles, wherein the diverging needles remain within the limits of the imaging field during treatment, and

wherein determining the location of the fibroid comprises rotating the visualization element and the imaging field about the longitudinal axis of the sheath independently of the plurality of diverging needles after the hollow needle has been advanced through the wall of the uterus and across the imaging filed.

2. A method as in claim 1 , wherein the sheath is introduced transcervically.

3. A method as in claim 1 , wherein the visualization element is ultrasonic and produces a visual image.

4. A method as in claim 3 , wherein introducing comprises manually positioning and penetrating the plurality of diverging needles through an endometrium so as to engage the fibroid.

5. A method as in claim 1 , wherein treating the fibroid comprises delivering ablative energy to the fibroid with the plurality of diverging needles.

6. A method as in claim 5 , wherein the ablative energy comprises radiofrequency energy, microwave energy, laser energy, cryo energy, ultrasound energy, HIFU, or radiation.

7. A method as in claim 6 , wherein the ablative energy comprises radiofrequency energy delivered in a bipolar or monopolar fashion.

8. A method as in claim 1 , wherein treating the fibroid comprises delivering at least one therapeutic agent to the fibroid with the plurality of diverging needles.

9. A method as in claim 1 , further comprising imaging advancing the hollow needle, advancing the plurality of diverging needles, and treatment in real-time with the visualization element.

10. A method as in claim 1 , further comprising monitoring tissue impedance.

11. A method as in claim 1 , further comprising measuring a tissue temperature so as to aid in diagnosis, blood supply measurement, thermal signature, or tissue targeting.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 070236/0154 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: GYNESONICS, INC.
Reel/Frame 075455/0789 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Feb 14, 2025
From: GYNESONICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 070236/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: GROSSMAN, JESSICA
To: GYNESONICS, INC.
Reel/Frame 043100/0783 →